Multiple biomarkers of colorectal tumor in a differential diagnosis model: A quantitative study

World Journal of Gastroenterology

Volumn 10, Issue 3, 2004, Pages 439-442

  Jin, Wen ^a   Gao, Mei Qin ^a   Lin, Zhi Wu ^b   Yang, Dai Xing ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; TUMOR MARKER;

ADENOMA; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER DIAGNOSIS; CELL NUCLEUS; CHROMOSOME NOR; CLINICAL TRIAL; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL TUMOR; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENSITY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DNA CONTENT; EARLY DIAGNOSIS; FEMALE; HUMAN; IMAGING SYSTEM; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; RECTUM MUCOSA; REPRODUCIBILITY; SAMPLE; SENSITIVITY AND SPECIFICITY;

EID: 1142287593     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i3.439     Document Type: Article

References (34)

1. Meng QK, Yang HM, Wang H. Clinical significance of DNA in colorectal carcinoma. Shiyong Zhongliuxue Zazhi 1999; 13: 93-94
2. Xu SY, Zhang YL, Zhou DY, Wen B. Computerized analysis of nuclear morphology in the differential diagnosis of protuberant colorectal lesions. Zhongguo Zhongliu Linchuang 1998; 25: 85-87
3. Derenzini M, Trere D, Pession A, Govoni M, Sirri V, Chieco P. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 2000; 191: 181-186
4. Eminovic-Behrem S, Trobonjaca Z, Petrovecki M, Dobi-Babic R, Dujmovic M, Jonjic N. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma. Croat Med J 2000; 41: 154-158
5. Feng S, Song JD, Tian XR. Significance of proliferating cell nuclear antigen expression in colorectal carcinoma. Hauren Xiaohua Zazhi 1998; 6: 146-147
6. Lavezzi AM, Ottaviani G, De Ruberto F, Fichera G, Matturri L. Prognostic significance of different biomarkers (DNA content, PCNA, karyotype) in colorectal adenomas. Anticancer Res 2002; 22: 2077-2081
7. Sugai T, Nakamura SI, Habano W, Uesugi N, Sato H, Yoshida T, Orii S. Usefulness of proliferative activity, DNA ploidy pattern and p53 products as diagnostic adjuncts in colorectal adenomas and intramucosal carcinomas. Pathol Int 1999; 49: 617-625
8. Freitas D, Goulao MH, Camacho E, Figueiredo P, Ministro P, Ferreira M, Portela F, Andrade P, Donato A, Martins MI. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: A prospective study. Hepatogastroenterology 2002; 49: 1269-1274
9. Zhuang XQ, Lai RQ, Sun GH, Wang XH, Luo ZQ, Yuan SZ. Expression and prognostic significance of p53 protein during colorectal tumorigenesis. Shijie Huaren Xiaohua Zazhi 1998; 6: 280-281
10. Di Stefano A, Fisichella P, Catanuto G, Di Blasi M, La Greca G, Grasso G, Russello D. Characterization and prognostic value of colorectal adenomas with molecular genetic markers. Minerva Chir 2000; 55: 99-104
11. Zhu WL, Li QX. An oncogene c-erbB-2 and cancer. Linchuang Yu Shiyan Binglixue Zazhi 1998; 14: 79-81
12. Wu W, Zhang X, Yan X, Wang J, Zhang J, Li Y. Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma. Zhonghua Zhongliu Zazhi 2002; 24: 264-267
13. He Q, Ohaki Y, Tanaka N, Asano G. The relationship between p53 protein and c-erb B-2 expression and apoptosis in colorectal cancer. Nippon Ika Daigaku Zasshi 1999; 66: 181-187
14. Xu LZ. AgNOR Standard Regimen. Aizheng 1996; 15: 75
15. Su JM, Zhou YP, Xu WL, Cao LH, Zha XL. E-Cadherin expression in four kinds of carcinoma and their relations to differentiation and metastasis. Chin J Cancer Res 2001; 13: 13-17
16. Pich A, Margaria E, Chiusa L. Significance of the AgNOR in tumor pathology. Pathologica 2002; 94: 2-9
17. Nakae S, Nakamura T, Ikegawa R, Yoshioka H, Shirono J, Tabuchi Y. Evaluation of argyrophilic nucleolar organizer region and proliferating cell nuclear antigen in colorectal cancer. J Surg Oncol 1998; 69: 28-35
18. Trere D. AgNOR staining and quantification. Micron 2000; 31: 127-131
19. Derenzini M, Trere D. Silver-stained Nucleolar Organizer Regions (AgNOR). Pathologica 2001; 93: 99-105
20. Derenzini M. The AgNORs. Micron 2000; 31: 117-120
21. Liu J, Zhao FD, Shi Y. Value of AgNORs determination in diagnosis of benign and malignant lesions of gastric mucosa. Practical J Cancer 1998; 13: 276-277
22. Tanaka K, Murata N, Yanai H, Okita K. Immunohistological study on the expression of proliferating cell nuclear antigen (PCNA/cyclin) in human colorectal lesions. Nippon Shokakibyo Gakkai Zassh 1992; 89: 493-497
23. Terzuoli L, Carlucci F, Martino AD, Frosi B, Porcelli B, Minacci C, Vernillo R, Baldi L, Marinello E, Pagani R, Tabucchi A. Determination of p185 and adenylosuccinate lyase (ASL) activity in preneoplastic colon lesions and intestinal musoca of human subjects. Clin Biochem 1998; 31: 523-528
24. Chang FH, Tzeng DS, Lee TM, Chen TC, Hsu LS, Lung FW. Mutations in the p53 tumor suppressor gene in colorectal cancer in Taiwan. Kaohsiun J Med Sci 2003; 19: 151-158
25. Sugai T, Takahashi H, Habano W, Nakamura S, Sato K, Orii S, Suzuki K. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. J Pathol 2003; 200: 168-176
26. Guzinska-Ustymowicz K, Sulkowska M, Famulski W, Sulkowski S. Tumour 'budding' and its relationship to p53 and Bcl-2 expression in colorectal cancer. Anticancer Res 2003; 23: 649-653
27. Kanavaros P, Stefanaki K, Valassiadou K, Vlachonikolis J, Mavromanolakis M, Vlychou M, Kakolyris S, Gorgoulis V, Tzardi M, Georgoulias V. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas. Med Oncol 1999; 16: 23-30
28. Sulkowska M, Famulski W, Guzinska-Ustymowicz K, Sulkowski S. Study of P53 protein expression in colorectal cancer. Folia Histochem Cytobiol 2001; 39: 157-158
29. Saleh HA, Jackson H, Banerjee M. Immunohistochemical expression of bcl-2 and p53 oncorproteins: Correlation with Ki67 proliferation index and prognostic histopathologic parameters in colorectal neoplasia. Appl Immunohistochem Mol Morphol 2000; 8: 175-182
30. Pignatelli M, Stamp GW, Kafiri G, Lane D, Bodmer WF. Over-expression of p53 nuclear oncoprotein in colorectal adenomas. Int J Cancer 1992; 50: 683-688
31. Porcelli B, Frosi B, Terzuoli L, Arezzini L, Marinello E, Vernillo R, De Martino A, Vatti R, Minacci C. Expresion of p185 and p53 in benign and malignant colorectal lesions. Histochem J 2001; 33: 51-57
32. Wu JT. C-erbB2 oncoprotein and its soluble ectodomain: A new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment. Clin Chim Acta 2002; 322: 11-19
33. Zhuang XQ, Lai RQ, Shun GH, Wang XH, Yuan SZ. p53 expression and PCNA expression as prognostic significance in colorectal neoplasmas. Shijie Huaren Xiaohua Zazhi 1999; 7: 616
34. McKay JA, Douglas JJ, Ross VG, Curran S, Loane JF, Ahmed FY, Cassidy J, McLeod HL, Murray GI. Analysis of key cell-cycle checkpoint proteins in colorectal tumours. J Pathol 2002; 196: 386-393